Low level of Hox1.3 gene expression does not preclude the use of promoterless vectors to generate a targeted gene disruption. off.
about
Gene trap mutagenesis of hnRNP A2/B1: a cryptic 3' splice site in the neomycin resistance gene allows continued expression of the disrupted cellular geneCreation of non-human primate neurogenetic disease models by gene targeting and nuclear transferComparative analysis of Hoxa5 allelic seriesMultiple promoters and alternative splicing: Hoxa5 transcriptional complexity in the mouse embryo.Gene targeting using a promoterless gene trap vector ("targeted trapping") is an efficient method to mutate a large fraction of genes.A large-scale gene-trap screen for insertional mutations in developmentally regulated genes in mice.Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse.Analysis of biological selections for high-efficiency gene targeting.The absence of the transcription activator TFE3 impairs activation of B cells in vivo.Mouse genetics in the 21st century: using gene targeting to create a cornucopia of mouse mutants possessing precise genetic modifications.Disruption of the adenosine deaminase (ADA) gene using a dicistronic promoterless construct: production of an ADA-deficient homozygote ES cell line.Gene targeting in human somatic cells. Complete inactivation of an interferon-inducible gene.Gene targeting in normal somatic cells: inactivation of the interferon-gamma receptor in myoblasts.Membrane-bound neomycin phosphotransferase confers drug-resistance in mammalian cells: a marker for high-efficiency targeting of genes encoding secreted and cell-surface proteins.The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse.
P2860
Q24798227-8B46CA2D-DD82-4174-BD17-13E30FCA1DA9Q24803689-F09FDF97-2243-418E-AED1-6CC2E3330C9CQ28590900-BACA6918-1FD8-427B-9F3E-3903AF11B699Q33582201-74989ECF-EBF7-4655-A750-D85FBAF19A7FQ33930218-770EF705-EBDD-43EF-838F-7F8E20AEA8CAQ33964573-CAAF9985-C4D8-4833-9E0D-98CA20DF9B7DQ36509326-6AAAD721-52AA-4046-93A6-7084DD624011Q36566296-EB7F369F-EB65-432E-A84B-5478530D52A0Q36568776-2AD4B414-EEDA-4FD3-916E-1DA625C81628Q40533324-2632221D-6C05-467A-B06B-96CC2D27DD3EQ41329252-AB131173-6903-48E7-982E-33C73D82C91BQ41513218-9454A852-8DB2-40FE-9617-7C3C4C85D43AQ45872568-E1631C3B-971D-4FBB-95ED-5B9CD5163F1AQ46173626-A28F37C5-F082-441A-9BFA-6FE9740023B4Q52202965-224E01D3-4C8E-43D5-820A-9BCB86A876C0
P2860
Low level of Hox1.3 gene expression does not preclude the use of promoterless vectors to generate a targeted gene disruption. off.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Low level of Hox1.3 gene expre ...... targeted gene disruption. off.
@en
type
label
Low level of Hox1.3 gene expre ...... targeted gene disruption. off.
@en
prefLabel
Low level of Hox1.3 gene expre ...... targeted gene disruption. off.
@en
P2093
P2860
P356
P1476
Low level of Hox1.3 gene expre ...... targeted gene disruption. off.
@en
P2093
E J Robertson
L Jeannotte
P2860
P304
P356
10.1128/MCB.11.11.5578
P407
P577
1991-11-01T00:00:00Z